Morgan Stanley’s Fibrocell Science Inc. FCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-49,900
| Closed | -$148K | – | 6911 |
|
|
2019
Q3 | $148K | Sell |
49,900
-10,000
| -17% | -$20.5K | ﹤0.01% | 5289 |
|
|
2019
Q2 | $114K | Buy |
59,900
+7,000
| +13% | +$14.3K | ﹤0.01% | 5265 |
|
|
2019
Q1 | $102K | Buy |
52,900
+25,440
| +93% | +$50.6K | ﹤0.01% | 5382 |
|
|
2018
Q4 | $41K | Buy |
27,460
+17,500
| +176% | +$35K | ﹤0.01% | 5811 |
|
|
2018
Q3 | $24K | Sell |
9,960
-1
| -0% | -$2 | ﹤0.01% | 6088 |
|
|
2018
Q2 | $27K | Sell |
9,961
-1,054
| -10% | -$3.05K | ﹤0.01% | 6080 |
|
|
2018
Q1 | $32K | Sell |
11,015
-219
| -2% | -$718 | ﹤0.01% | 6015 |
|
|
2017
Q4 | $36K | Sell |
11,234
-5,646
| -33% | -$49.4K | ﹤0.01% | 5928 |
|
|
2017
Q3 | $259K | Buy |
16,880
+9,534
| +130% | +$154K | ﹤0.01% | 5225 |
|
|
2017
Q2 | $147K | Buy |
7,346
+5,686
| +343% | +$70.2K | ﹤0.01% | 5485 |
|
|
2017
Q1 | $17K | Sell |
1,660
-25
| -1% | -$277 | ﹤0.01% | 6129 |
|
|
2016
Q4 | $16K | Sell |
1,685
-1,720
| -51% | -$18.5K | ﹤0.01% | 6056 |
|
|
2016
Q3 | $36K | Sell |
3,405
-1,312
| -28% | -$19.5K | ﹤0.01% | 5721 |
|
|
2016
Q2 | $81K | Buy |
4,717
+547
| +13% | +$17K | ﹤0.01% | 5338 |
|
|
2016
Q1 | $156K | Sell |
4,170
-1,163
| -22% | -$46.4K | ﹤0.01% | 5110 |
|
|
2015
Q4 | $365K | Buy |
5,333
+2,504
| +89% | +$180K | ﹤0.01% | 4749 |
|
|
2015
Q3 | $163K | Buy |
2,829
+2,376
| +525% | +$210K | ﹤0.01% | 5190 |
|
|
2015
Q2 | $36K | Sell |
453
-1,763
| -80% | -$119K | ﹤0.01% | 5979 |
|
|
2015
Q1 | $150K | Buy |
2,216
+406
| +22% | +$26.1K | ﹤0.01% | 5345 |
|
|
2014
Q4 | $70K | Sell |
1,810
-1,339
| -43% | -$54.1K | ﹤0.01% | 5700 |
|
|
2014
Q3 | $138K | Buy |
3,149
+534
| +20% | +$25K | ﹤0.01% | 5327 |
|
|
2014
Q2 | $157K | Buy |
2,615
+2,164
| +480% | +$121K | ﹤0.01% | 5274 |
|
|
2014
Q1 | $35K | Buy |
451
+388
| +616% | +$30.1K | ﹤0.01% | 5831 |
|
|
2013
Q4 | $4K | Buy |
+63
| New | +$3.67K | ﹤0.01% | 6193 |
|
Morgan Stanley's FCSC Position: Q4 2019 in Review
Morgan Stanley sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 49,900 shares — an estimated $148K sold.
Morgan Stanley first reported a position in FCSC in Q4 2013 and held it in 24 quarters. The position peaked at $365K in Q4 2015. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.
- Morgan Stanley reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
- Morgan Stanley sold 49,900 Fibrocell Science Inc. shares in Q4 2019, an estimated $148K.
- Morgan Stanley first reported a position in Fibrocell Science Inc. in Q4 2013 and held it in 24 quarters.
- Morgan Stanley's Fibrocell Science Inc. position peaked at $365K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.
Based on Morgan Stanley's 13F filing for Q4 2019, filed 14 Feb 2020.